Conditional and Unconditioanl Elasticties (3SLS/SUR) at Mean Shares |
Created via SAS program <model-estimate-AIDS-ver01.sas> |
Notes on Estimation
Note 1: Includes segment122 (Metadate CD/ER and Ritalin SR/LA cobmined via med-equivalence)
Note 2: Includes segments 503 (Drugs combined via med-equivalence)
Note 3: Fixed Effects: State Level for all segments
-------------------- 3SLS RESULTS -------------------- |
Share of Each Molecule | |||
---|---|---|---|
MPH | MAS | DEX | OFF-Lables + |
0.455 | 0.281 | 0.034 | 0.230 |
u: Mid-Level Shares (Share of Forms within Molecule) | ||||||||
---|---|---|---|---|---|---|---|---|
MPH-IR | MPH-ER | MPH-OROS | MAS-IR | MAS-ER | DEX-IR | DEX-ER | Off-Labels+ (5 Drugs) |
|
ROW1 | 0.292 | 0.171 | 0.537 | 0.571 | 0.429 | 0.323 | 0.677 | 1.000 |
s: Bottom Level Shares (Within Molecule-Form) | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ritalin | Methylin | Generics (MPH-IR) | Ritalin SRLA | Metadate ERCD | MethylinER | Generics (MPH-ER) | Concerta | Aderall | Generic (MAS-IR) | Aderall XR | Dexederine | Dextrostat | Generics (DEX-IR) | Dexederine SR | Generics (DEX-ER) | Offlabels | |
ROW1 | 0.251 | 0.208 | 0.541 | 0.294 | 0.297 | 0.098 | 0.311 | 1.000 | 0.564 | 0.436 | 1.000 | 0.531 | 0.083 | 0.385 | 0.589 | 0.411 | 1.000 |
Absolute Shares of Each Drug | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ritalin | Methylin | Generics (MPH-IR) | Ritalin SRLA | Metadate ERCD | MethylinER | Generics (MPH-ER) | Concerta | Aderall | Generic (MAS-IR) | Aderall XR | Dexederine | Dextrostat | Generics (DEX-IR) | Dexederine SR | Generics (DEX-ER) | Offlabels | |
ROW1 | 0.033 | 0.028 | 0.072 | 0.023 | 0.023 | 0.008 | 0.024 | 0.244 | 0.090 | 0.070 | 0.120 | 0.006 | 0.001 | 0.004 | 0.013 | 0.009 | 0.230 |
Unconditional Marshallian Elasticities | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ritalin | Methylin | Generics (MPH-IR) | Ritalin SRLA | Metadate ERCD | MethylinER | Generics (MPH-ER) | Concerta | Aderall | Generic (MAS-IR) | Aderall XR | Dexederine | Dextrostat | Generics (DEX-IR) | Dexederine SR | Generics (DEX-ER) | Offlabels | |
Ritalin | -1.263 | 0.139 | 0.403 | -0.258 | -0.260 | -0.086 | -0.273 | 0.948 | 0.007 | 0.006 | 0.010 | -0.066 | -0.010 | -0.048 | -0.154 | -0.108 | -0.250 |
Methylin | 0.258 | -0.347 | -0.277 | -0.131 | -0.132 | -0.044 | -0.139 | 0.482 | 0.004 | 0.003 | 0.005 | -0.034 | -0.005 | -0.024 | -0.078 | -0.055 | -0.127 |
Generics (MPH-IR) | 0.242 | -0.135 | -0.611 | -0.180 | -0.182 | -0.060 | -0.191 | 0.663 | 0.005 | 0.004 | 0.007 | -0.046 | -0.007 | -0.034 | -0.108 | -0.075 | -0.175 |
Ritalin SRLA | -0.333 | -0.275 | -0.718 | -2.130 | -0.077 | 0.478 | 0.061 | 2.404 | 0.007 | 0.005 | 0.009 | -0.060 | -0.009 | -0.044 | -0.140 | -0.098 | -0.228 |
Metadate ERCD | -0.250 | -0.207 | -0.539 | 0.046 | -1.316 | -0.065 | 0.083 | 1.805 | 0.005 | 0.004 | 0.007 | -0.045 | -0.007 | -0.033 | -0.105 | -0.073 | -0.171 |
MethylinER | -0.292 | -0.241 | -0.630 | 1.493 | -0.259 | -1.945 | -0.752 | 2.108 | 0.006 | 0.005 | 0.008 | -0.053 | -0.008 | -0.038 | -0.123 | -0.086 | -0.200 |
Generics (MPH-ER) | -0.249 | -0.205 | -0.536 | 0.182 | 0.082 | -0.215 | -1.293 | 1.794 | 0.005 | 0.004 | 0.007 | -0.045 | -0.007 | -0.033 | -0.104 | -0.073 | -0.170 |
Concerta | 0.091 | 0.075 | 0.196 | 0.185 | 0.187 | 0.062 | 0.196 | -1.528 | 0.006 | 0.005 | 0.008 | -0.055 | -0.009 | -0.040 | -0.127 | -0.089 | -0.207 |
Aderall | 0.002 | 0.001 | 0.004 | 0.001 | 0.001 | 0.000 | 0.001 | 0.013 | -1.419 | 0.189 | 0.149 | 0.156 | 0.024 | 0.113 | 0.362 | 0.253 | -1.036 |
Generic (MAS-IR) | 0.001 | 0.001 | 0.002 | 0.001 | 0.001 | 0.000 | 0.001 | 0.006 | 0.631 | -1.176 | 0.066 | 0.069 | 0.011 | 0.050 | 0.161 | 0.112 | -0.459 |
Aderall XR | 0.001 | 0.001 | 0.003 | 0.001 | 0.001 | 0.000 | 0.001 | 0.010 | 0.069 | 0.053 | -0.990 | 0.126 | 0.020 | 0.091 | 0.291 | 0.203 | -0.832 |
Dexederine | -0.024 | -0.020 | -0.051 | -0.016 | -0.016 | -0.005 | -0.017 | -0.175 | 0.243 | 0.188 | 0.323 | -1.608 | 0.873 | 0.014 | 0.154 | 0.107 | -1.261 |
Dextrostat | -0.048 | -0.039 | -0.102 | -0.032 | -0.033 | -0.011 | -0.034 | -0.348 | 0.484 | 0.374 | 0.645 | 5.198 | -7.600 | 0.963 | 0.306 | 0.214 | -2.516 |
Generics (DEX-IR) | -0.017 | -0.014 | -0.037 | -0.012 | -0.012 | -0.004 | -0.012 | -0.125 | 0.174 | 0.135 | 0.232 | 0.127 | 0.284 | -0.929 | 0.110 | 0.077 | -0.905 |
Dexederine SR | -0.029 | -0.024 | -0.062 | -0.020 | -0.020 | -0.007 | -0.021 | -0.211 | 0.293 | 0.227 | 0.390 | 0.090 | 0.014 | 0.065 | -0.967 | 0.241 | -1.523 |
Generics (DEX-ER) | -0.012 | -0.010 | -0.026 | -0.008 | -0.008 | -0.003 | -0.009 | -0.089 | 0.124 | 0.096 | 0.165 | 0.038 | 0.006 | 0.028 | 0.592 | -0.898 | -0.643 |
Offlabels | 0.030 | 0.025 | 0.064 | 0.020 | 0.021 | 0.007 | 0.022 | 0.218 | -0.242 | -0.187 | -0.322 | -0.127 | -0.020 | -0.092 | -0.293 | -0.205 | 0.011 |
Conditional Elastcities (Marshallian/Hicksian/H-Allen/Expendiure) & Shares | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Ritalin | Methylin | Generics (MPH-IR) | Ritalin | Methylin | Generics (MPH-IR) | Ritalin | Methylin | Generics (MPH-IR) | Exp | Share | |
Ritalin | -1.42 | 0.01 | 0.06 | -1.08 | 0.29 | 0.79 | -4.31 | 1.39 | 1.47 | 1.36 | 0.25 |
Methylin | 0.18 | -0.41 | -0.45 | 0.35 | -0.27 | -0.08 | 1.39 | -1.30 | -0.15 | 0.69 | 0.21 |
Generics (MPH-IR) | 0.13 | -0.23 | -0.85 | 0.37 | -0.03 | -0.34 | 1.47 | -0.15 | -0.62 | 0.95 | 0.54 |
Conditional Elastcities (Marshallian/Hicksian/H-Allen/Expendiure) & Shares | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ritalin SRLA | Metadate ERCD | MethylinER | Generics (MPH-ER) | Ritalin SRLA | Metadate ERCD | MethylinER | Generics (MPH-ER) | Ritalin SRLA | Metadate ERCD | MethylinER | Generics (MPH-ER) | Exp | Share | |
Ritalin SRLA | -1.99 | 0.06 | 0.52 | 0.21 | -1.64 | 0.42 | 0.64 | 0.58 | -5.58 | 1.41 | 6.54 | 1.86 | 1.20 | 0.29 |
Metadate ERCD | 0.15 | -1.21 | -0.03 | 0.19 | 0.41 | -0.94 | 0.06 | 0.47 | 1.41 | -3.18 | 0.59 | 1.52 | 0.90 | 0.30 |
MethylinER | 1.61 | -0.14 | -1.90 | -0.62 | 1.92 | 0.18 | -1.80 | -0.30 | 6.54 | 0.59 | -18.37 | -0.95 | 1.05 | 0.10 |
Generics (MPH-ER) | 0.29 | 0.19 | -0.18 | -1.18 | 0.55 | 0.45 | -0.09 | -0.91 | 1.86 | 1.52 | -0.95 | -2.91 | 0.89 | 0.31 |
Conditional Elastcities (Marshallian/Hicksian/H-Allen/Expendiure) & Shares | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
MPH-IR | MPH-ER | MPH-OROS | MPH-IR | MPH-ER | MPH-OROS | MPH-IR | MPH-ER | MPH-OROS | Exp | Share | |
MPH-IR | -0.66 | -0.72 | 0.45 | -0.39 | -0.56 | 0.95 | -1.34 | -3.30 | 1.77 | 0.93 | 0.29 |
MPH-ER | -1.24 | -1.47 | 1.75 | -0.96 | -1.31 | 2.27 | -3.30 | -7.66 | 4.23 | 0.96 | 0.17 |
MPH-OROS | 0.21 | 0.54 | -1.80 | 0.52 | 0.72 | -1.24 | 1.77 | 4.23 | -2.31 | 1.05 | 0.54 |
Conditional Elastcities (Marshallian/Hicksian/H-Allen/Expendiure) & Shares | ||||||||
---|---|---|---|---|---|---|---|---|
Aderall | Generic (MAS-IR) | Aderall | Generic (MAS-IR) | Aderall | Generic (MAS-IR) | Exp | Share | |
Aderall | -1.47 | 0.15 | -0.73 | 0.73 | -1.29 | 1.66 | 1.32 | 0.56 |
Generic (MAS-IR) | 0.61 | -1.19 | 0.94 | -0.94 | 1.66 | -2.15 | 0.59 | 0.44 |
Conditional Elastcities (Marshallian/Hicksian/H-Allen/Expendiure) & Shares | ||||||||
---|---|---|---|---|---|---|---|---|
MAS-IR | MAS-ER | MAS-IR | MAS-ER | MAS-IR | MAS-ER | Exp | Share | |
MAS-IR | -1.02 | 0.05 | -0.46 | 0.46 | -0.81 | 1.08 | 0.97 | 0.57 |
MAS-ER | 0.03 | -1.06 | 0.62 | -0.62 | 1.08 | -1.44 | 1.03 | 0.43 |
Conditional Elastcities (Marshallian/Hicksian/H-Allen/Expendiure) & Shares | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Dexederine | Dextrostat | Generics (DEX-IR) | Dexederine | Dextrostat | Generics (DEX-IR) | Dexederine | Dextrostat | Generics (DEX-IR) | Exp | Share | |
Dexederine | -1.77 | 0.85 | -0.10 | -1.22 | 0.93 | 0.29 | -2.30 | 11.22 | 0.76 | 1.03 | 0.53 |
Dextrostat | 4.87 | -7.65 | 0.73 | 5.96 | -7.48 | 1.52 | 11.22 | -89.98 | 3.94 | 2.05 | 0.08 |
Generics (DEX-IR) | 0.01 | 0.27 | -1.01 | 0.40 | 0.33 | -0.73 | 0.76 | 3.94 | -1.89 | 0.74 | 0.39 |
Conditional Elastcities (Marshallian/Hicksian/H-Allen/Expendiure) & Shares | ||||||||
---|---|---|---|---|---|---|---|---|
Dexederine SR | Generics (DEX-ER) | Dexederine SR | Generics (DEX-ER) | Dexederine SR | Generics (DEX-ER) | Exp | Share | |
Dexederine SR | -1.31 | -0.00 | -0.54 | 0.54 | -0.92 | 1.31 | 1.31 | 0.59 |
Generics (DEX-ER) | 0.45 | -1.00 | 0.77 | -0.77 | 1.31 | -1.88 | 0.55 | 0.41 |
Conditional Elastcities (Marshallian/Hicksian/H-Allen/Expendiure) & Shares | ||||||||
---|---|---|---|---|---|---|---|---|
DEX-IR | DEX-ER | DEX-IR | DEX-ER | DEX-IR | DEX-ER | Exp | Share | |
DEX-IR | -0.89 | -0.15 | -0.56 | 0.56 | -1.72 | 0.82 | 1.04 | 0.32 |
DEX-ER | -0.05 | -0.93 | 0.27 | -0.27 | 0.82 | -0.39 | 0.98 | 0.68 |
Conditional Elastcities (Marshallian/Hicksian/H-Allen/Expendiure) & Shares | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MPH | MAS | DEX | OFF-Lables + | MPH | MAS | DEX | OFF-Lables + | MPH | MAS | DEX | OFF-Lables + | Exp | Share | |
MPH | -0.51 | 0.02 | -0.30 | -0.20 | -0.06 | 0.30 | -0.27 | 0.03 | -0.13 | 1.06 | -8.00 | 0.14 | 1.00 | 0.45 |
MAS | 0.02 | -0.84 | 0.71 | -0.80 | 0.44 | -0.58 | 0.74 | -0.59 | 0.96 | -2.07 | 21.78 | -2.57 | 0.92 | 0.28 |
DEX | -0.30 | 0.71 | -0.43 | -1.18 | 0.25 | 1.05 | -0.39 | -0.90 | 0.54 | 3.73 | -11.54 | -3.92 | 1.21 | 0.03 |
OFF-Lables + | 0.41 | -0.75 | -0.74 | 0.01 | 0.89 | -0.45 | -0.70 | 0.26 | 1.96 | -1.61 | -20.67 | 1.12 | 1.07 | 0.23 |
Estimates of the Top Level Equation |
|
---|---|
B | Gamma |
0.41282 | -1.153073 |
-------------------- SUR RESULTS --------------------- |
Share of Each Molecule | |||
---|---|---|---|
MPH | MAS | DEX | OFF-Lables + |
0.455 | 0.281 | 0.034 | 0.230 |
u: Mid-Level Shares (Share of Forms within Molecule) | ||||||||
---|---|---|---|---|---|---|---|---|
MPH-IR | MPH-ER | MPH-OROS | MAS-IR | MAS-ER | DEX-IR | DEX-ER | Off-Labels+ (5 Drugs) |
|
ROW1 | 0.292 | 0.171 | 0.537 | 0.571 | 0.429 | 0.323 | 0.677 | 1.000 |
s: Bottom Level Shares (Within Molecule-Form) | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ritalin | Methylin | Generics (MPH-IR) | Ritalin SRLA | Metadate ERCD | MethylinER | Generics (MPH-ER) | Concerta | Aderall | Generic (MAS-IR) | Aderall XR | Dexederine | Dextrostat | Generics (DEX-IR) | Dexederine SR | Generics (DEX-ER) | Offlabels | |
ROW1 | 0.251 | 0.208 | 0.541 | 0.294 | 0.297 | 0.098 | 0.311 | 1.000 | 0.564 | 0.436 | 1.000 | 0.531 | 0.083 | 0.385 | 0.589 | 0.411 | 1.000 |
Absolute Shares of Each Drug | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ritalin | Methylin | Generics (MPH-IR) | Ritalin SRLA | Metadate ERCD | MethylinER | Generics (MPH-ER) | Concerta | Aderall | Generic (MAS-IR) | Aderall XR | Dexederine | Dextrostat | Generics (DEX-IR) | Dexederine SR | Generics (DEX-ER) | Offlabels | |
ROW1 | 0.033 | 0.028 | 0.072 | 0.023 | 0.023 | 0.008 | 0.024 | 0.244 | 0.090 | 0.070 | 0.120 | 0.006 | 0.001 | 0.004 | 0.013 | 0.009 | 0.230 |
Unconditional Marshallian Elasticities | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ritalin | Methylin | Generics (MPH-IR) | Ritalin SRLA | Metadate ERCD | MethylinER | Generics (MPH-ER) | Concerta | Aderall | Generic (MAS-IR) | Aderall XR | Dexederine | Dextrostat | Generics (DEX-IR) | Dexederine SR | Generics (DEX-ER) | Offlabels | |
Ritalin | -0.761 | -0.019 | 0.212 | -0.268 | -0.271 | -0.089 | -0.284 | 0.833 | 0.050 | 0.038 | 0.066 | -0.084 | -0.013 | -0.061 | -0.196 | -0.137 | -0.273 |
Methylin | 0.047 | 0.017 | -0.354 | -0.137 | -0.138 | -0.046 | -0.145 | 0.425 | 0.025 | 0.020 | 0.034 | -0.043 | -0.007 | -0.031 | -0.100 | -0.070 | -0.139 |
Generics (MPH-IR) | 0.141 | -0.159 | -0.382 | -0.189 | -0.191 | -0.063 | -0.200 | 0.587 | 0.035 | 0.027 | 0.047 | -0.059 | -0.009 | -0.043 | -0.138 | -0.096 | -0.192 |
Ritalin SRLA | -0.351 | -0.290 | -0.756 | -0.463 | -0.074 | 0.031 | -0.021 | 1.341 | 0.045 | 0.035 | 0.060 | -0.076 | -0.012 | -0.055 | -0.176 | -0.123 | -0.246 |
Metadate ERCD | -0.262 | -0.217 | -0.565 | -0.034 | -0.052 | -0.204 | -0.104 | 1.002 | 0.033 | 0.026 | 0.045 | -0.057 | -0.009 | -0.041 | -0.132 | -0.092 | -0.184 |
MethylinER | -0.279 | -0.230 | -0.601 | 0.123 | -0.624 | 0.830 | -0.750 | 1.066 | 0.036 | 0.027 | 0.047 | -0.061 | -0.009 | -0.044 | -0.140 | -0.098 | -0.196 |
Generics (MPH-ER) | -0.262 | -0.216 | -0.565 | 0.019 | -0.099 | -0.233 | -0.081 | 1.002 | 0.033 | 0.026 | 0.044 | -0.057 | -0.009 | -0.041 | -0.132 | -0.092 | -0.184 |
Concerta | 0.079 | 0.065 | 0.171 | 0.100 | 0.101 | 0.033 | 0.106 | -1.200 | 0.042 | 0.032 | 0.055 | -0.071 | -0.011 | -0.051 | -0.164 | -0.115 | -0.229 |
Aderall | 0.012 | 0.010 | 0.026 | 0.008 | 0.008 | 0.003 | 0.009 | 0.087 | -1.276 | 0.316 | 0.054 | 0.097 | 0.015 | 0.070 | 0.224 | 0.156 | -1.052 |
Generic (MAS-IR) | 0.005 | 0.004 | 0.012 | 0.004 | 0.004 | 0.001 | 0.004 | 0.039 | 0.706 | -1.139 | 0.024 | 0.044 | 0.007 | 0.032 | 0.101 | 0.071 | -0.475 |
Aderall XR | 0.009 | 0.007 | 0.019 | 0.006 | 0.006 | 0.002 | 0.006 | 0.065 | 0.034 | 0.027 | -0.739 | 0.072 | 0.011 | 0.052 | 0.168 | 0.117 | -0.788 |
Dexederine | -0.029 | -0.024 | -0.062 | -0.020 | -0.020 | -0.007 | -0.021 | -0.212 | 0.138 | 0.107 | 0.184 | -0.781 | 0.997 | -0.007 | -0.287 | -0.201 | -0.970 |
Dextrostat | -0.068 | -0.056 | -0.145 | -0.046 | -0.047 | -0.015 | -0.049 | -0.494 | 0.323 | 0.250 | 0.430 | 6.518 | -6.428 | 0.396 | -0.671 | -0.469 | -2.267 |
Generics (DEX-IR) | -0.020 | -0.017 | -0.044 | -0.014 | -0.014 | -0.005 | -0.015 | -0.150 | 0.098 | 0.076 | 0.130 | -0.042 | 0.057 | 0.132 | -0.204 | -0.142 | -0.688 |
Dexederine SR | -0.037 | -0.030 | -0.079 | -0.025 | -0.025 | -0.008 | -0.027 | -0.269 | 0.176 | 0.136 | 0.234 | -0.159 | -0.025 | -0.115 | 0.111 | -0.168 | -1.233 |
Generics (DEX-ER) | -0.017 | -0.014 | -0.036 | -0.011 | -0.011 | -0.004 | -0.012 | -0.122 | 0.080 | 0.062 | 0.106 | -0.072 | -0.011 | -0.052 | -0.223 | 0.197 | -0.559 |
Offlabels | -0.042 | -0.034 | -0.090 | -0.029 | -0.029 | -0.010 | -0.030 | -0.306 | -0.072 | -0.055 | -0.095 | -0.087 | -0.014 | -0.063 | -0.201 | -0.140 | 0.240 |
Conditional Elastcities (Marshallian/Hicksian/H-Allen/Expendiure) & Shares | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Ritalin | Methylin | Generics (MPH-IR) | Ritalin | Methylin | Generics (MPH-IR) | Ritalin | Methylin | Generics (MPH-IR) | Exp | Share | |
Ritalin | -0.96 | -0.18 | -0.21 | -0.62 | 0.10 | 0.52 | -2.46 | 0.48 | 0.96 | 1.35 | 0.25 |
Methylin | -0.05 | -0.07 | -0.57 | 0.12 | 0.08 | -0.20 | 0.48 | 0.37 | -0.36 | 0.69 | 0.21 |
Generics (MPH-IR) | 0.00 | -0.27 | -0.68 | 0.24 | -0.08 | -0.17 | 0.96 | -0.36 | -0.31 | 0.95 | 0.54 |
Conditional Elastcities (Marshallian/Hicksian/H-Allen/Expendiure) & Shares | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ritalin SRLA | Metadate ERCD | MethylinER | Generics (MPH-ER) | Ritalin SRLA | Metadate ERCD | MethylinER | Generics (MPH-ER) | Ritalin SRLA | Metadate ERCD | MethylinER | Generics (MPH-ER) | Exp | Share | |
Ritalin SRLA | -0.66 | -0.28 | -0.04 | -0.23 | -0.31 | 0.08 | 0.08 | 0.14 | -1.05 | 0.28 | 0.84 | 0.46 | 1.21 | 0.29 |
Metadate ERCD | -0.18 | -0.20 | -0.25 | -0.26 | 0.08 | 0.06 | -0.17 | 0.02 | 0.28 | 0.22 | -1.68 | 0.06 | 0.90 | 0.30 |
MethylinER | -0.04 | -0.78 | 0.78 | -0.92 | 0.25 | -0.50 | 0.87 | -0.62 | 0.84 | -1.68 | 8.89 | -1.99 | 0.96 | 0.10 |
Generics (MPH-ER) | -0.13 | -0.25 | -0.28 | -0.24 | 0.13 | 0.02 | -0.19 | 0.04 | 0.46 | 0.06 | -1.99 | 0.13 | 0.90 | 0.31 |
Conditional Elastcities (Marshallian/Hicksian/H-Allen/Expendiure) & Shares | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
MPH-IR | MPH-ER | MPH-OROS | MPH-IR | MPH-ER | MPH-OROS | MPH-IR | MPH-ER | MPH-OROS | Exp | Share | |
MPH-IR | -0.55 | -0.75 | 0.37 | -0.28 | -0.59 | 0.87 | -0.96 | -3.47 | 1.62 | 0.93 | 0.29 |
MPH-ER | -1.29 | -0.51 | 0.86 | -1.01 | -0.35 | 1.37 | -3.47 | -2.07 | 2.54 | 0.94 | 0.17 |
MPH-OROS | 0.17 | 0.25 | -1.48 | 0.47 | 0.43 | -0.91 | 1.62 | 2.54 | -1.69 | 1.06 | 0.54 |
Conditional Elastcities (Marshallian/Hicksian/H-Allen/Expendiure) & Shares | ||||||||
---|---|---|---|---|---|---|---|---|
Aderall | Generic (MAS-IR) | Aderall | Generic (MAS-IR) | Aderall | Generic (MAS-IR) | Exp | Share | |
Aderall | -1.48 | 0.16 | -0.73 | 0.73 | -1.30 | 1.69 | 1.31 | 0.56 |
Generic (MAS-IR) | 0.62 | -1.21 | 0.95 | -0.95 | 1.69 | -2.18 | 0.59 | 0.44 |
Conditional Elastcities (Marshallian/Hicksian/H-Allen/Expendiure) & Shares | ||||||||
---|---|---|---|---|---|---|---|---|
MAS-IR | MAS-ER | MAS-IR | MAS-ER | MAS-IR | MAS-ER | Exp | Share | |
MAS-IR | -0.91 | -0.10 | -0.34 | 0.34 | -0.59 | 0.78 | 1.01 | 0.57 |
MAS-ER | -0.12 | -0.87 | 0.45 | -0.45 | 0.78 | -1.04 | 0.99 | 0.43 |
Conditional Elastcities (Marshallian/Hicksian/H-Allen/Expendiure) & Shares | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Dexederine | Dextrostat | Generics (DEX-IR) | Dexederine | Dextrostat | Generics (DEX-IR) | Dexederine | Dextrostat | Generics (DEX-IR) | Exp | Share | |
Dexederine | -1.42 | 0.90 | -0.47 | -0.89 | 0.98 | -0.09 | -1.68 | 11.78 | -0.23 | 1.00 | 0.53 |
Dextrostat | 5.02 | -6.66 | -0.69 | 6.26 | -6.47 | 0.21 | 11.78 | -77.81 | 0.54 | 2.34 | 0.08 |
Generics (DEX-IR) | -0.50 | -0.01 | -0.20 | -0.12 | 0.05 | 0.08 | -0.23 | 0.54 | 0.20 | 0.71 | 0.39 |
Conditional Elastcities (Marshallian/Hicksian/H-Allen/Expendiure) & Shares | ||||||||
---|---|---|---|---|---|---|---|---|
Dexederine SR | Generics (DEX-ER) | Dexederine SR | Generics (DEX-ER) | Dexederine SR | Generics (DEX-ER) | Exp | Share | |
Dexederine SR | -0.61 | -0.68 | 0.14 | -0.14 | 0.25 | -0.35 | 1.29 | 0.59 |
Generics (DEX-ER) | -0.55 | -0.03 | -0.21 | 0.21 | -0.35 | 0.50 | 0.59 | 0.41 |
Conditional Elastcities (Marshallian/Hicksian/H-Allen/Expendiure) & Shares | ||||||||
---|---|---|---|---|---|---|---|---|
DEX-IR | DEX-ER | DEX-IR | DEX-ER | DEX-IR | DEX-ER | Exp | Share | |
DEX-IR | -0.03 | -0.98 | 0.30 | -0.30 | 0.92 | -0.44 | 1.01 | 0.32 |
DEX-ER | -0.46 | -0.53 | -0.14 | 0.14 | -0.44 | 0.21 | 1.00 | 0.68 |
Conditional Elastcities (Marshallian/Hicksian/H-Allen/Expendiure) & Shares | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MPH | MAS | DEX | OFF-Lables + | MPH | MAS | DEX | OFF-Lables + | MPH | MAS | DEX | OFF-Lables + | Exp | Share | |
MPH | -0.51 | 0.12 | -0.39 | -0.22 | -0.06 | 0.40 | -0.36 | 0.01 | -0.13 | 1.43 | -10.51 | 0.06 | 1.00 | 0.45 |
MAS | 0.12 | -0.68 | 0.42 | -0.80 | 0.55 | -0.42 | 0.46 | -0.58 | 1.20 | -1.50 | 13.47 | -2.52 | 0.93 | 0.28 |
DEX | -0.39 | 0.42 | -0.28 | -0.96 | 0.16 | 0.76 | -0.24 | -0.68 | 0.35 | 2.72 | -6.97 | -2.96 | 1.20 | 0.03 |
OFF-Lables + | -0.57 | -0.22 | -0.50 | 0.24 | -0.09 | 0.07 | -0.47 | 0.48 | -0.19 | 0.26 | -13.83 | 2.10 | 1.06 | 0.23 |
Estimates of the Top Level Equation |
|
---|---|
B | Gamma |
0.4028419 | -0.741354 |